Health News

Omega-3 and low-dose aspirin matched the effectiveness of antibiotics in a year-long study of patients with severe gum disease, with both approaches helping about 58% reach the treatment goal. The unexpected result could point to a new way to treat some patients while reducing reliance on antibiotics and the growing problem of antibiotic resistance.

Adults aged 40 and older performed about 12% faster on a test of executive function after using a HEPA air purifier at home for one month. The findings suggest that cleaner indoor air could offer a simple way to help protect the brain from the effects of traffic-related pollution.

Researchers have produced a form of Spirulina containing biologically active vitamin B12 at levels comparable to beef. By carefully controlling the light used to grow the algae, they overcame a major problem with conventional Spirulina, which mainly contains a form of B12 the human body cannot use. The carbon-neutral system could provide a more sustainable source of the essential vitamin.

CAR T-cell therapy dramatically reduced disease activity in six people with severe rheumatoid arthritis that had resisted other treatments, with three achieving medication-free remission. The treatment may work by clearing out harmful immune cells and effectively rebooting part of the immune system, although much larger studies are still needed.

A ketogenic diet outperformed Mediterranean and low-fat diets in several measures of metabolic health during a clinical trial involving people with obesity, prediabetes, and fatty liver disease. All three groups lost about 10% of their body weight, but keto reduced liver fat by 67%, compared with 45% for the other diets. About half of the keto group also no longer qualified as having prediabetes after four to five months.

Dogs and humans may have more in common when it comes to aging than scientists realized. Researchers with the Dog Aging Project found that patterns of small molecules in dogs’ blood were linked to longer or shorter lifespans in remarkably similar ways to those seen in people. These metabolic “fingerprints” could offer clues about the biological processes that drive aging, including metabolism, inflammation, and cellular stress.

People with chronic insomnia who used melatonin long term had a roughly 90% higher risk of developing heart failure over five years, according to a large preliminary study. The findings do not prove melatonin causes heart problems, but they raise new questions about the safety of taking the popular sleep supplement for extended periods.

Frequent micro-awakenings during sleep were linked to higher genetic risk for Alzheimer’s in healthy middle-aged adults who had no symptoms. The discovery raises the possibility that subtle changes during sleep could offer an early warning signal years before memory problems appear.

Scientists have identified a protein that acts like a brake on the nervous system’s ability to repair damaged connections. Blocking AHR helped injured nerve fibers regrow and improved movement and sensation in mice with nerve or spinal cord injuries. The discovery could eventually point toward new treatments designed to shift neurons from simply surviving an injury to actively rebuilding themselves.

Scientists have created light-activated drugs that helped blind mice perceive light again and restored visually guided behavior without gene therapy, implants, or specialized lighting. Even more intriguingly, two of the most promising compounds worked when administered as eye drops, pointing toward a potentially simple new approach to restoring vision.